ad image

COPD

1 / 1
Developing a Novel Anti-Inflammatory for Patients with Severe Asthma
Respiratory Diseases

Developing a Novel Anti-Inflammatory for Patients with Severe Asthma

Robert Clarke, Ph.D

Kinaset Therapeutics

PAO-02-022-CL-13Mar 12, 2022
Boehringer Ingelheim
Clinical Data

New Data Reinforces Benefits of Spiolto® Respimat® in Improving Patient Outcomes

Boehringer Ingelheim

PR-M10-19-NI-001Oct 01, 2019
Mylan and Theravance Will Receive FDA Decision on COPD Drug by November
Drug Development

Mylan and Theravance Will Receive FDA Decision on COPD Drug by November

Guy Tiene

Nice Insight

PAO-M02-18-NI-006Feb 06, 2018
COPD Patients Excited about AstraZeneca Trial Results
Clinical Trials

COPD Patients Excited about AstraZeneca Trial Results

Guy Tiene

Nice Insight

PAO-M02-18-NI-002Feb 01, 2018
1 / 1